Tools

Search

Explore

Videos Channels Figures

Atmrix

About

Tools

Search

Explore

Videos Channels Figures

Atmrix

About

MS

Michael Skok

03/25/23

@ Harvard Innovation Labs

Focusing on biopharma companies as a target market allows for a more tailored data solution that meets their specific needs.

Video

HI

Designing a Customer-Centric Business Model

@ Harvard Innovation Labs

Designing a Customer-Centric Business Model

03/25/23

Related Takeaways

EI

Elizabeth Iorns

09/14/17

@ Y Combinator

The focus for biotech companies is on de-risking their technology by obtaining experimental data and developing a viable therapeutic intervention, which is crucial before entering clinical trials.

AW

Alexandr Wang

06/18/25

@ Y Combinator

Our strategy involves focusing on a small number of high-profile customers, including leading companies in pharmaceuticals, telecommunications, banking, and healthcare, as well as government agencies.

PB

Paul Buchheit

03/07/18

@ Y Combinator

When evaluating biotech companies, the demand for their product is often clear, but the challenge lies in their ability to deliver on that promise.

EI

Elizabeth Iorns

10/03/18

@ Y Combinator

The future of biotech will likely involve products that patients are willing to pay for, focusing on conditions that significantly impact their quality of life.

YC

Y Combinator Cast

02/24/15

@ Y Combinator

We have received many applications from hardware and biotech companies, and we are adapting our approach to support their longer growth timelines.

JL

Jonathan Lim

04/30/25

@ a16z

The last few years have been sobering for the biotech industry, highlighting the need to adapt quickly to survive amidst fierce competition for attention from investors, partners, and talent.

HI

Harvard Innovation Labs Cast

06/12/13

@ Harvard Innovation Labs

Narrowing your target market to a specific segment with a critical need can lead to greater success than trying to appeal to a broad audience.

EI

Elizabeth Iorns

10/03/18

@ Y Combinator

Access to capital and FDA's development strategies for rare diseases have enabled small biotech companies to bring products to market without being acquired.

EI

Elizabeth Iorns

09/14/17

@ Y Combinator

Biotech fundraising is increasingly resembling traditional paths seen in software, with many funds showing interest in innovative science companies.